Bioxytran (BIXT) EBIT Margin (QoQ) (2010 - 2018)
Bioxytran (BIXT) EBIT Margin (QoQ) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Bioxytran | 2.29 Mn | 2.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 368.00 |
| Mar 31, 2018 | 26,342.00 |
| Dec 31, 2017 | -31,384.00 |
| Sep 30, 2017 | 70,021.00 |
| Jun 30, 2017 | 18,752.00 |
| Mar 31, 2017 | -107,812.00 |
| Dec 31, 2016 | 44,544.00 |
| Sep 30, 2016 | 4,808.00 |
| Jun 30, 2016 | 117,951.00 |
| Mar 31, 2016 | -144,270.00 |
| Dec 31, 2015 | 3,087.00 |
| Sep 30, 2015 | 319,691.00 |
| Jun 30, 2015 | -316,278.00 |
| Mar 31, 2015 | -151,612.00 |
| Dec 31, 2014 | 414,181.00 |
| Sep 30, 2014 | -253,683.00 |
| Jun 30, 2014 | -17,996.00 |
| Mar 31, 2014 | 9,412.00 |
| Dec 31, 2013 | 43,128.00 |
| Sep 30, 2013 | 14,480.00 |